Transaction in Own Shares

Summary by AI BETAClose X

Legal & General Group Plc has purchased 5,819,363 of its ordinary shares between March 30, 2026, and April 2, 2026, as part of its share buyback program announced on March 11, 2026. These repurchased shares will be cancelled, reducing the total number of ordinary shares in issue to 5,673,682,428, which also represents the total number of voting rights. The purchases were executed through the company's broker, Barclays Capital Securities Limited, with prices ranging from 240.00 to 255.30 pence per share.

Disclaimer*

Legal & General Group Plc
07 April 2026
 

LEGAL & GENERAL GROUP PLC
ISIN: GB0005603997
7th April 2026

 

LEI number: 213800JH9QQWHLO99821

 

Legal & General Group Plc (the "Company")
Transaction in Own Shares


The Company announces that from 30th March 2026 up to and including 2nd April 2026 it had purchased a total of 5,819,363 of its ordinary shares of 2.5 pence each (the "ordinary shares"), through the Company's broker Barclays Capital Securities Limited as detailed below. The repurchased ordinary shares will be cancelled.

Date

Aggregate number of ordinary shares purchased

Highest price paid (per ordinary share)

Lowest price paid (per ordinary share)

Volume weighted average price

 

Trading venue

30th March 2026

565,116

244.40

240.00

241.93

XLON

30th March 2026

255,017

244.30

240.20

241.98

BATE

30th March 2026

285,229

244.30

240.00

241.73

TRQX

30th March 2026

195,070

244.40

240.20

242.50

AQXE

30th March 2026

499,568

244.40

240.00

241.99

CHIX

31st March 2026

519,823

248.30

244.60

247.21

XLON

31st March 2026

219,392

248.40

244.70

247.08

BATE

31st March 2026

217,678

248.30

244.70

247.02

TRQX

31st March 2026

183,914

248.30

244.70

247.27

AQXE

31st March 2026

459,193

248.30

244.60

247.11

CHIX

1st April 2026

353,077

255.20

252.70

254.29

XLON

1st April 2026

218,507

255.30

252.40

254.13

BATE

1st April 2026

249,214

255.20

252.40

254.15

TRQX

1st April 2026

173,144

255.20

252.40

254.15

AQXE

1st April 2026

306,058

255.30

252.40

254.20

CHIX

2nd April 2026

507,709

253.90

252.20

252.90

XLON

2nd April 2026

111,336

253.50

252.10

252.74

BATE

2nd April 2026

107,890

253.40

252.10

252.73

TRQX

2nd April 2026

148,820

253.40

252.20

252.84

AQXE

2nd April 2026

243,608

253.90

252.10

252.82

CHIX


The purchases form part of the Company's share buyback programme announced on 11th March 2026.

Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue shall be 5,673,682,428 ordinary shares.

No ordinary shares are held in treasury. Therefore, the total number of voting rights in the Company is 5,673,682,428.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as incorporated into and implemented under English law (including by virtue of the European Union (Withdrawal) Act 2018), the detailed breakdown of individual trades made by Barclays Capital Securities Limited on behalf of the Company as part of the share buyback programme is set out below.

http://www.rns-pdf.londonstockexchange.com/rns/5108Z_1-2026-4-7.pdf

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings